E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers A > Headlines for AEterna Zentaris Inc. > News item
Published on 5/9/2014 in the Prospect News PIPE Daily.

Aeterna announces $15 million at-the-market issuance sales agreement

Offering sells up to 14,018,692 common shares at market prices via MLV

By Devika Patel

Knoxville, Tenn., May 9 - Aeterna Zentaris Inc. said it arranged a $15 million at-the-market issuance sales agreement with MLV & Co. LLC.

The agent will sell up to 14,018,692 common shares at market prices.

Aeterna Zentaris is an oncology and endocrinology drug development company based in Quebec City.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.